Medical University of South Carolina

TC BioPharm Announces New Chair of the Board, Arlene Morris

Retrieved on: 
Tuesday, February 14, 2023
Biotechnology, MicroRNA, Medical University of South Carolina, BIO, PLC, Carlow University, Holding, Bremelanotide, TC, Silicon, Therapy, Female, Chairperson, Humane society, Medical school, Carlow College, Cancer, Pharmaceutical industry, Management, Cogent, Biology

EDINBURGH, Scotland, Feb. 14, 2023 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced the appointment of Arlene M. Morris to the position of Chair of the Board.

Key Points: 
  • EDINBURGH, Scotland, Feb. 14, 2023 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced the appointment of Arlene M. Morris to the position of Chair of the Board.
  • Ms. Morris has held a seat on the TC BioPharm board as an independent director since 2022.
  • Her leadership in business development and strategic marketing offer unique oversight to the company as TC BioPharm advances through clinical trials.
  • "I am honored to take on the responsibility as Chair for TC BioPharm at such a pivotal time in the company's growth trajectory," said Morris.

Award Winning Infection Preventionist Shapes DNV’s Approach to Infection Prevention

Retrieved on: 
Thursday, January 26, 2023
ASCP, DNV, MBA, Education, Infection, Safety, CIC, Certification, ASPC, CIP, RN, Hospital, Association for Professionals in Infection Control and Epidemiology, MPH, Conference, Ministry of Education (Malaysia), Patient, APIC, BSN, Medical University of South Carolina, Medicine, Pharmaceutical industry

She has played a pivotal role in guiding both DNV’s Certification in Infection Prevention (CIP) for hospitals, and the Advanced Sterile Processing Program Certification (ASPC).

Key Points: 
  • She has played a pivotal role in guiding both DNV’s Certification in Infection Prevention (CIP) for hospitals, and the Advanced Sterile Processing Program Certification (ASPC).
  • “In 2022, Leslie achieved noteworthy accomplishments in her work with Infection Prevention,” stated Michelle W. King, MT (ASCP), MPH, CIC (Current APIC SC Palmetto Chapter President).
  • She has also participated as a presenter on the topic of infection prevention for webinars and conferences around the globe.
  • APIC’s national award, “Heroes in Infection Prevention,” was presented to Leslie and her DNV colleague, Jeremy Gibson-Roark RN, CIC, at the 2021 National APIC Conference.

Clinical trial to test wearable device as treatment for chronic pain, opioid withdrawal

Retrieved on: 
Tuesday, January 17, 2023
Neuroimaging, Addiction, Tan, Brain, University, Vagus nerve stimulation, Anesthesiology, Doctor of Philosophy, Trigeminal nerve, Department of Pharmacology, University College London, Tandem, Principal investigator, Chronic pain, Psychiatry, FDA, Research, Trigeminal neuralgia, UTMB, Death, VNS, History, Patient, Behavioural sciences, Howard Brody, Stroke, Analgesic, Cranial nerves, Pain, TNS, Medical University of South Carolina, MUSC, Vagus nerve, Magnetic resonance, Pain management, Medical school, Opioid use disorder, Dentistry, Pharmaceutical industry, Cereal, Medical imaging, Sparrow, Pharmacology

“Our collaborative project will determine the efficacy of tAN to ease tapering of real-world patients from opioid management of chronic pain with reduced withdrawal symptoms.

Key Points: 
  • “Our collaborative project will determine the efficacy of tAN to ease tapering of real-world patients from opioid management of chronic pain with reduced withdrawal symptoms.
  • Importantly, neurostimulation therapy will provide a much needed and innovative treatment option over existing opioid analgesics with high risk for misuse, opioid use disorder, and overdose.”
    Amid the opioid epidemic, a treatment chasm has emerged.
  • Countless patients are being encouraged to avoid or discontinue opioid use for acute pain relief and chronic pain conditions for which opioids are a daily necessity.
  • Spark Biomedical developed the Sparrow Therapy System—the first FDA-cleared wearable, non-invasive tAN device for the treatment of opioid withdrawal.

MAPS PBC Announces Frontiers in Psychiatry Published First Study to Evaluate Neural Impact of MDMA-Assisted Therapy in Patients with PTSD

Retrieved on: 
Thursday, January 19, 2023
Brain, Amygdala, Medical University of South Carolina, MDMA, Fear, Anxiety, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Safety, Frontiers, MD, FDA, Trauma, Breakthrough therapy, MAPS, Radiology, PBC, Food, Patient, Post-traumatic stress disorder, SAN, Male, MRI, Magnetic resonance, FC, Veteran, Neuroscience, Female, Medical school, Hippocampus, Meat, Medical imaging, Pharmaceutical industry, PTSD, Psychiatry

Results showed that changes in functional connectivity between brain regions implicated1 in PTSD were associated with a reduction in PTSD severity following treatment with MDMA-assisted therapy.

Key Points: 
  • Results showed that changes in functional connectivity between brain regions implicated1 in PTSD were associated with a reduction in PTSD severity following treatment with MDMA-assisted therapy.
  • One participant began the trial with mode rate PTSD (CAPS-IV > 39) while the remaining eight presented with severe PTSD (CAPS-IV > 59).
  • MAPS PBC expects to submit the new drug application to the FDA in the third quarter of 2023.
  • The safety and efficacy of MDMA-assisted therapy have not been established for the treatment of PTSD.

Spectral Medical Provides Update on Tigris Clinical Trial and Other Business Developments

Retrieved on: 
Thursday, January 12, 2023
Medical school, Hospital, PMX, Acute, Medical University of South Carolina, Hemoperfusion, Standard of care, Dialysis, EDEN, TSX, FDA, Total, Randomized controlled trial, Knowledge, Partnership, EAA, SAMI, Death, Marketing, Lipopolysaccharide, Patient, Sepsis, Observational study, Mortality, Clinical trial, Intensive care unit, Baxter, CDC, Septic shock, Pharmaceutical industry, Health insurance, Q4

TORONTO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided a business update focusing on Tigris, the Company’s follow-on study designed to build on knowledge gained from the earlier EUPHRATES trial, which evaluated the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. The Tigris trial end point is a reduction in the 28-day mortality in subjects with septic shock using the PMX hemoperfusion cartridge versus standard of care.

Key Points: 
  • The Tigris trial end point is a reduction in the 28-day mortality in subjects with septic shock using the PMX hemoperfusion cartridge versus standard of care.
  • Chris Seto, Chief Executive Officer of Spectral Medical, commented, “We continue to aggressively advance our Tigris trial with 50 of the 150 total patients now enrolled and randomized in the study.
  • Moreover, we have seen a 30-40% increase in sepsis cases at our trial sites compared to last summer.
  • To meet final trial enrollment in 2023, we estimate the need for approximately 20 productive trial sites.

Rany T. Abdallah, MD, Ph.D., is recognized by Continental Who's Who

Retrieved on: 
Wednesday, January 4, 2023
University, Quality of life, American Academy, ABA, Psychotherapy, American Board of Anesthesiology, Patient, Headache, Pain management, Continental, Travel, Private practice, North American Neuromodulation Society, Faculty, International Neuromodulation Society, Twilight anesthesia, Rush University, Cancer pain, Millsboro, Medical Society, Medicine, Chronic pain, Neck pain, SCJ World Academy, Medical school, Doctor of Philosophy, Fibromyalgia, Spine, Pain, MBA, Human, World Institute of Pain, Society, American Board of Commissioners for Foreign Missions, Medical University of South Carolina, Abdominal pain, Dentistry, Neuroscience, MD, Bear, Anesthesiology

Dr. Abdallah earned his medical degree and Doctor of Philosophy degree (Ph.D.) at the Medical University of South Carolina.

Key Points: 
  • Dr. Abdallah earned his medical degree and Doctor of Philosophy degree (Ph.D.) at the Medical University of South Carolina.
  • Dr. Abdallah is the Owner/President of APICO Pain Management, serving patients in the Bear, Dover, and Millsboro areas.
  • A pain management specialist is a doctor who specializes in pain medicine, focusing on the evaluation, treatment, and prevention of pain.
  • In his free time, Dr. Abdallah likes to travel and is fluent in English, Arabic, French, and Spanish.

Indee Labs Partners With Monomer Bio to Automate Engineered Immune Cell Culture

Retrieved on: 
Thursday, December 1, 2022
Software, Social capital, Labs, Multimedia, Machine learning, Partnership, Medical University of South Carolina, Biotechnology, UCSF, Medical school, Founders Fund, Y Combinator, GMP, Buffer, Electroporation, Stanford University, Automation, Research, Algorithm, Vaccine, Fine chemical, Indee Gold Mine, Science

BERKELEY, Calif. and PACIFICA, Calif., Dec. 1, 2022 /PRNewswire/ -- Indee Labs is a biotechnology company developing the Hydropore™ for non-viral intracellular delivery. Monomer Bio enables cell culture at scale by providing intelligent automation software that allows labs to build fully automated workcells using readily available equipment.

Key Points: 
  • Indee Labs partners with Monomer Bio to automate Hydroporeworkflows for engineered T cells and similar immune cell types.
  • Monomer Bio enables cell culture at scale by providing intelligent automation software that allows labs to build fully automated workcells using readily available equipment.
  • Indee Labs partners with Monomer Bio to automate cell culture workflows for engineered immune cells.
  • Monomer Bio is a venture backed team of experienced operators and works with some of the most cutting-edge biotech companies like Indee Labs, Science, E11, and Modulo Bio.

Avianne P. Bunnell, MD, RPVI is recognized by Continental Who's Who

Retrieved on: 
Monday, November 28, 2022
UCF, Basic life support, Medical University of South Carolina, University, Advanced trauma life support, Society for Vascular Surgery, Multimedia, Medical school, Varicose veins, Society, Central Florida, Laser, Vein, Aneurysm, College of Medicine, Advanced cardiac life support, The Vein, RPVI, SPRING, Stroke, Continental, Dentistry, MD

SPRING HILL, Fla., Nov. 28, 2022 /PRNewswire/ -- Avianne P. Bunnell, MD, RPVI, is being recognized by Continental Who's Who as an Outstanding Medical Professional in acknowledgment of her outstanding work at The Vein and Vascular Institute.

Key Points: 
  • SPRING HILL, Fla., Nov. 28, 2022 /PRNewswire/ -- Avianne P. Bunnell, MD, RPVI, is being recognized by Continental Who's Who as an Outstanding Medical Professional in acknowledgment of her outstanding work at The Vein and Vascular Institute.
  • Dr. Avianne Bunnell is a board-certified in vascular surgery and is highly skilled in the most cutting-edge and advanced technologies in vascular care.
  • With eight years of experience, Dr. Bunnell is a vascular surgeon passionate about providing compassionate and unsurpassed clinical and surgical care.
  • Dr. Bunnell is also certified Registered Physician in Vascular Interpretation (RPVI), meaning she is certified to read and interpret all vascular ultrasounds.

Clinical Insights: Medical Solutions Welcomes New Chief Nursing Officer Patti Artley

Retrieved on: 
Monday, November 14, 2022
Aureus, Workforce, Hospital, Patti, Tupelo, Rising Medical Solutions, Medical University of South Carolina, Nursing, Safety, Growth, Joint, Medical school, Joint Commission, Travel, Medicine, Artley, Healthcare Facilities Accreditation Program

Omaha, NE, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Medical Solutions, one of the nations largest providers of total workforce solutions serving the healthcare industry, is pleased to welcome Patti Artley as the companys Chief Nursing Officer.

Key Points: 
  • Omaha, NE, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Medical Solutions, one of the nations largest providers of total workforce solutions serving the healthcare industry, is pleased to welcome Patti Artley as the companys Chief Nursing Officer.
  • Most recently, Artley served as Chief Nursing Officer at Medical University of South Carolina.
  • The team and I are thrilled to have Patti leading our clinical team, said Craig Meier, Chief Executive Officer at Medical Solutions.
  • She looks forward to lending her experiences in internal staffing solutions and clinical nurse leadership to the growth of Medical Solutions.

Notable Survey: 61% of Patients Skip Medical Appointments Due to Scheduling Hassles

Retrieved on: 
Monday, November 14, 2022
Health, Practice Management, Technology, Health Technology, Software, Automation, Investment, Patient satisfaction, Falk, Health, ICONIQ, Intermountain Healthcare, Multimedia, Health care, Growth, Medical University of South Carolina, MUSC, Frustration, Medical school, Population health, Patient, Pharmaceutical industry, Health insurance, Greylock Partners, Notability

61% of patients surveyed said that they skipped going to the doctor in the past year because scheduling an appointment was too much of a hassle.

Key Points: 
  • 61% of patients surveyed said that they skipped going to the doctor in the past year because scheduling an appointment was too much of a hassle.
  • Theyre avoiding medical visits because the appointment-booking process is confusing and takes far too much time and effort.
  • In addition to challenges with scheduling appointments, the survey revealed increasing patient frustration with time spent waiting to see their doctor.
  • Engaging tens of millions of patients per year, Notable is leveraged by leading health systems, including Intermountain Healthcare and Medical University of South Carolina (MUSC).